Listado de Ponencias del XV Symposium GETNE 2019
Mesa 1
Optimizing Somatostatin Analogues use in NETs Antongiulio Faggiano, MD, PhD
Optimizing PRRT-based therapy in NETs Tessa Brabander, MD, PhD
Optimizing Chemotherapy in G1-G2 GEP-NET Jonathan Strosberg, MD Professor
Optimisation approach with anti-targeted therapies in NETs Dra. Angela Lamarca
Mesa 2
Radiological criteria and techniques for evaluation of response to systemic treatment Dra. Ana Fernández del Valle
Nutritional considerations on patients with NETs Dra. Inmaculada Peiró
Mesa 3
Multidisciplinary approach to incidental/incipient gastric, duodenal and rectal NETs Dr. Jose Díaz Tasende No disponible
Multidisciplinary approach to incidental/incipient pancreatic NETs Dra. Elena Martín Pérez
Mesa 4
Unveiling the molecular pathways underlying the development of lung neuroendocrine neoplasms Lynnette Fernandez-Cuesta, Ph.D.
Pheochromocytoma/Paragangliomas: epigenetic silencing of protocadherins Dra. Nueria Valdés Gallego
New therapeutic strategy in Anaplastic Thyroid Carcinoma Dra. Clara V. Alvarez
Mesa 5
Where are the limits for the treatment with I131 for advanced differentiated thyroid cancer? Dr. Carles Zafon
Advanced differentiated thyroid cancer: clinical criteria to guide the treatment sequence Dra. Teresa Ramón y Cajal
Advanced medullary thyroid cancer: clinical criteria to guide the therapeutical sequence and dose Lara Iglesias MD
Mesa 6
Investigación con RWD: aspectos clave en tumores neuroendocrinos Dr. Alberto Carmona Bayonas